CAR T-cell therapy is revolutionizing cancer treatment by harnessing the power of the immune system. By reprogramming patients’ own T-cells to attack cancer, it’s achieving unprecedented success rates in once untreatable cancers.
Breaking Ground in Cancer Research: Iron-Targeting Compounds Show Promise in Halting Cancer Cell Growth. Researchers at the University of Arizona Cancer Center unveil a potential game-changer.
Professor Li Tang’s groundbreaking research enhances CAR-T cell therapy by introducing a new dimension to target solid tumors. Co-founding Leman Biotech with Yugang Guo, Tang’s bioengineered CAR-T cells excrete the IL-10 molecule, traditionally seen as an immune suppressant. Rather than inhibiting the immune response, this innovation reinforces metabolic capabilities, addressing the challenge of CAR-T cells […]
Thiophene F-8 exhibits remarkable anti-cancer properties by inducing programmed cell death, known as apoptosis, specifically in leukemia and lymphoma cells. This compound interferes with crucial cellular processes, disrupting the cancer cells’ survival mechanisms. Through targeted interactions with specific molecular pathways involved in cell proliferation, thiophene F-8 triggers a cascade of events leading to apoptosis. By […]
